EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.332 24 days ( 15.28 % )
Last Price $7.07 -4.20 %
High/ Low $7.07 - $7.35 1.49%
Chg 7 Days -3.42 % $7.32 $7.07
Chg 30 Days -14.09 % $8.23 $7.07
Chg 12 mos 115.55 % $3.28 $7.07
Trend - 3 mos -25.50 % Width: 39.92 %
Trend - 12 mos 94.81 % Width: 111.72 %
Pred. range - 3 mos $4.76 - $6.66 -32.69 % - -5.82 %
Pred. range - 12 mos $12.15 - $25.73 71.92 % - 263.99 %
Short MA avg 3 mos Sell Jun 14, 2024 - 7 days
Long MA avg 3 mos Buy May 02, 2024 - 37 days
Short/Long MA avg 3 mos Sell Apr 19, 2024 - 46 days
Short MA avg 12 mos Buy May 28, 2024 - 20 days
Long MA avg 12 mos Sell Jun 13, 2024 - 8 days
Short/Long MA avg 12 mos Sell Jun 21, 2024 - 3 days
Pivot Short Sell May 03, 2024 - 36 days
Bollinger Buy Feb 08, 2024 - 95 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Mind Medicine (MindMed) Inc. Subordinate Voting Shares

Mind Medicine (MindMed). Subordinate Voting Shares Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has co... MNMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT